Panacea Biotec Q1 net dips 48.63 pc to Rs 16.72 cr
Panacea Biotec today said its net profit declined by 48.63 per cent to Rs 16.72 crore for the quarter ended June 30, 2011 over the same period previous fiscal.
By PTI |
NEW DELHI: Drug firm Panacea Biotec today said its net profit declined by 48.63 per cent to Rs 16.72 crore for the quarter ended June 30, 2011 over the same period previous fiscal.
The company had posted a net profit of Rs 32.55 crore for the quarter ended June 30, 2010, Panacea Biotec said in a filing to the Bombay Stock Exchange (BSE).
Total income of the company declined to Rs 225.69 crore for the quarter ended June 30, 2011 from Rs 258.41 crore for the corresponding period previous fiscal.
Commenting on the results, Panacea Biotec Joint Managing Director Rajesh Jain said: "The nature of our business does not allow uniform result and growth on quarterly basis. It is more rational to measure the performance on yearly basis".
During the quarter the company launched eight new products, Panacea Biotec said.
Shares of Panacea Biotec today closed at Rs 170 on BSE, up 0.92 per cent from its previous close.
The company had posted a net profit of Rs 32.55 crore for the quarter ended June 30, 2010, Panacea Biotec said in a filing to the Bombay Stock Exchange (BSE).
Total income of the company declined to Rs 225.69 crore for the quarter ended June 30, 2011 from Rs 258.41 crore for the corresponding period previous fiscal.
Commenting on the results, Panacea Biotec Joint Managing Director Rajesh Jain said: "The nature of our business does not allow uniform result and growth on quarterly basis. It is more rational to measure the performance on yearly basis".
During the quarter the company launched eight new products, Panacea Biotec said.
Shares of Panacea Biotec today closed at Rs 170 on BSE, up 0.92 per cent from its previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
